HUP2200323A1 - Új avapritinib sók és elõállítási eljárásaik - Google Patents
Új avapritinib sók és elõállítási eljárásaikInfo
- Publication number
- HUP2200323A1 HUP2200323A1 HU2200323A HUP2200323A HUP2200323A1 HU P2200323 A1 HUP2200323 A1 HU P2200323A1 HU 2200323 A HU2200323 A HU 2200323A HU P2200323 A HUP2200323 A HU P2200323A HU P2200323 A1 HUP2200323 A1 HU P2200323A1
- Authority
- HU
- Hungary
- Prior art keywords
- salts
- avapritinib
- preparing
- novel
- methods
- Prior art date
Links
- DWYRIWUZIJHQKQ-SANMLTNESA-N (1S)-1-(4-fluorophenyl)-1-[2-[4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl]pyrimidin-5-yl]ethanamine Chemical class Cn1cc(cn1)-c1cc2c(ncnn2c1)N1CCN(CC1)c1ncc(cn1)[C@@](C)(N)c1ccc(F)cc1 DWYRIWUZIJHQKQ-SANMLTNESA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU2200323A HUP2200323A1 (hu) | 2022-08-11 | 2022-08-11 | Új avapritinib sók és elõállítási eljárásaik |
PCT/HU2023/050049 WO2024033668A1 (en) | 2022-08-11 | 2023-08-10 | Novel avapritinib salts and methods for preparing the salts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU2200323A HUP2200323A1 (hu) | 2022-08-11 | 2022-08-11 | Új avapritinib sók és elõállítási eljárásaik |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP2200323A1 true HUP2200323A1 (hu) | 2024-02-28 |
Family
ID=89851060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU2200323A HUP2200323A1 (hu) | 2022-08-11 | 2022-08-11 | Új avapritinib sók és elõállítási eljárásaik |
Country Status (2)
Country | Link |
---|---|
HU (1) | HUP2200323A1 (hu) |
WO (1) | WO2024033668A1 (hu) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3136707A1 (en) * | 2019-04-12 | 2020-10-15 | Blueprint Medicines Corporation | Crystalline forms of (s)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1h-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making |
EP4118084A1 (en) * | 2020-03-11 | 2023-01-18 | Teva Czech Industries s.r.o. | Solid state forms of avapritinib and process for preparation thereof |
US20230279009A1 (en) * | 2020-06-17 | 2023-09-07 | Teva Czech Industries S.R.O | Solid state forms of avapritinib salts |
-
2022
- 2022-08-11 HU HU2200323A patent/HUP2200323A1/hu unknown
-
2023
- 2023-08-10 WO PCT/HU2023/050049 patent/WO2024033668A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2024033668A1 (en) | 2024-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL291033A (en) | rip1 inhibitory compounds and methods for their preparation and use | |
HUE052049T2 (hu) | Kristályos 2-fluor-3-nitrotoluol és eljárás annak elõállítására | |
IL290781A (en) | rip1 inhibitory compounds and methods for their preparation and use | |
EP3828170A4 (en) | PROCESS FOR THE SAFE PREPARATION OF PIMAVANSERIN AND ITS TARTRATE SALT USING TRIPHOSGEN | |
EP3950660A4 (en) | PROCESS FOR THE PREPARATION OF DIMETHYL CARBONATE | |
SG11202008002PA (en) | A microorganism producing a mycosporine-like amino acid and a method for producing a mycosporine-like amino acid using the same | |
IL290921A (en) | Transformed plants and methods for their preparation and use | |
EP3929191A4 (en) | Method for preparing voriconazole and intermediate thereof | |
ZA202107474B (en) | Sulcardine salts | |
EP3814358A4 (en) | METHOD FOR PREPARING A 2-INDOLINOSPIRONE COMPOUND AND INTERMEDIATE THEREOF | |
EP3986870A4 (en) | NEW CRYSTALLINE FORM OF OLAPARIB AND PROCESS OF PRODUCTION | |
GB202008327D0 (en) | Method for preparing 2,2'dipyridine and derivatives thereof | |
ZA202200964B (en) | Salts of a compound, crystal forms of the salts and preparation method and use thereof | |
PT3687279T (pt) | Meio de crescimento horticultural e método para preparar o meio de crescimento | |
EP4081028A4 (en) | 25-HYDROXY-CHOLEST-5-EN-3-CRYSTALLINE SODIUM SULFATE AND LIQUID CRYSTALLINE AND METHODS OF PREPARATION THEREOF | |
EP4055009C0 (en) | METHOD OF MANUFACTURING DEXMEDETOMIDINE | |
GB2584128B (en) | Methods for cultivating Sphagnum | |
EP3744711A4 (en) | PROCESS FOR THE PREPARATION OF MESACONIN AND RELATED INTERMEDIARIES | |
HUP2200323A1 (hu) | Új avapritinib sók és elõállítási eljárásaik | |
EP3787680A4 (en) | HSV-2-DELTA-GD VACCINES, PRODUCTION METHODS AND USES | |
SG11202007544RA (en) | Water soluble salts of lipidated peptides and methods for preparing and using the same | |
ZA202202618B (en) | Card and method for producing the card | |
IL292304A (en) | A co-processed stimulant preparation, which is stable and effervescent, and a process for its preparation | |
GB2595411B (en) | Method for making tea cubes using micronized tea and tea cubes made by the method | |
IL287105A (en) | Processes for the preparation of pyrrolidine alpha-carboxamide derivatives |